다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie, v.141, 2021년, pp.111876 -
Zhang, Jiamei (College of Chinese Medicine, Beijing University of Chinese Medicine) , Sun, Huihui (College of Traditional Chinese Medicine, Beijing University of Chinese Medicine) , Jiang, KunXiu (College of Chinese Medicine, Beijing University of Chinese Medicine) , Song, Xingzhuo (College of Chinese Medicine, Beijing University of Chinese Medicine) , Wang, Xirui (College of Chinese Medicine, Beijing University of Chinese Medicine) , Yang, Yuqian (College of Chinese Medicine, Beijing University of Chinese Medicine) , Liu, Hanying (College of Traditional Chinese Medicine, Beijing University of Chinese Medicine) , Ji, Qingxuan (College of Traditional Chinese Medicine, Beijing University of Chinese Medicine) , Yu, Xue (College of Traditional Chinese Medicine, Beijing University of Chinese Medicine) , Liu, Yonggang (College of Chinese Medicine, Beijing University of Chinese Medicine) , Han, Jing (In) , Wang, Wei
AI-Helper
Abstract Gastric cancer (GC) is one of the most common malignancies and has the second highest lethal rate in the world; thus, finding new medicines with high potency and low toxicity is urgent. Cudrania tricuspidata (Carr.) Bur. ex Lavallee (Moraceae) is a traditional medicinal herb that is consid...
Expert Rev. Mol. Diagn. Röcken 17 293 2017 10.1080/14737159.2017.1286985 Molecular classification of gastric cancer
Helicobacter Venerito 21 39 2016 10.1111/hel.12339 Gastric cancer - clinical and epidemiological aspects
Med Sci. Monit. Tan 25 3537 2019 10.12659/MSM.916475 Recent Advances in the Surgical Treatment of Advanced Gastric Cancer: A Review
Updates Surg. Strong 70 157 2018 10.1007/s13304-018-0543-3 Progress in gastric cancer
Ann. Oncol. Aoyama 28 1876 2017 10.1093/annonc/mdx236 Early results of a randomized two-by-two factorial phase II trial comparing neoadjuvant chemotherapy with two and four courses of cisplatin/S-1 and docetaxel/cisplatin/S-1 as neoadjuvant chemotherapy for locally advanced gastric cancer
Hematol. /Oncol. Clin. North Am. Hayes 31 427 2017 10.1016/j.hoc.2017.02.002 Staging in Esophageal and Gastric Cancers
J. Ethnopharmacol. Jeon 194 57 2016 10.1016/j.jep.2016.08.042 Cudraticusxanthone A isolated from the roots of Cudrania tricuspidata inhibits metastasis and induces apoptosis in breast cancer cells
J. Qufu Norm. Univ. (Nat. Sci. ). Shi 36 88 2010 Study Progress on Chemical Component and Pharmacological Action of Cudrania Tricuspidata (Carr.) Bur
PLoS ONE Kwon 11 2016 Cudrania tricuspidata Stem Extract Induces Apoptosis via the Extrinsic Pathway in SiHa Cervical Cancer Cells
Pharm. Biol. Kim 56 192 2018 10.1080/13880209.2018.1447972 Anti-neuroinflammatory effects of cudraflavanone A isolated from the chloroform fraction of Cudrania tricuspidata root bark
Nat. Prod. Commun. Nile 10 1839 2015 Antioxidant, Anti-inflammatory and Xanthine Oxidase Inhibitory Activity of Cudrania tricuspidata
Cudrania tricuspidata syrup, Chinese Journal of Pharmaceuticals. 12 (1977) 65.
Brain Res. Ding 915 210 2001 10.1016/S0006-8993(01)02852-9 Long-term neuroprotective effect of inhibiting poly(ADP-ribose) polymerase in rats with middle cerebral artery occlusion using a behavioral assessment
J. Chin. Med. Mater. Jiang 575 2008 Screening of effective anti-tumor parts of Cudrania tricuspidata
Medicine Xie 39 602 2017 Inhibitory effect of Cudrania tricuspidata extract on gastrointestinal tumors, Chinese Traditional Patent
Crit. Rev. Food Sci. Nutr. Li 60 494 2020 10.1080/10408398.2018.1541866 Bioactive compounds from Cudrania tricuspidata: A natural anticancer source
J. Nat. Prod. Lee 68 456 2005 10.1021/np030481a Cytotoxic Xanthones from Cudrania t ricuspidata
Bioorg. Med. Chem. Lett. Lee 15 5548 2005 10.1016/j.bmcl.2005.08.099 Antioxidant and cytotoxic activities of xanthones from Cudrania tricuspidata
Role Angiogenesis Cancer Treat., Biomed. Rajab 5 2017
Reprod. Toxicol. Ribatti 70 97 2017 10.1016/j.reprotox.2016.11.004 The chick embryo chorioallantoic membrane (CAM) assay
J. Pathol. Timmer 196 125 2002 10.1002/path.1028 Fas receptor-mediated apoptosis: a clinical application?
Nagata 87 1996 Apoptosis, Springer Berlin Heidelberg, Berlin, Heidelberg Apoptosis Mediated by the Fas System
Chem. Biodivers. Klein‐Júnior 17 2020 10.1002/cbdv.201900499 Xanthones and Cancer: from Natural Sources to Mechanisms of Action
Molecules Yang 18 15305 2013 10.3390/molecules181215305 In Vitro and In Vivo Antiangiogenic Activity of Caged Polyprenylated Xanthones Isolated from Garcinia hanburyi Hook. f
Microvasc. Res. Jittiporn 93 72 2014 10.1016/j.mvr.2014.03.005 Anti-angiogenic actions of the mangosteen polyphenolic xanthone derivative α-mangostin
Am. J. Chin. Med. Lee 43 1439 2015 10.1142/S0192415X15500810 Cudraxanthone H Induces Growth Inhibition and Apoptosis in Oral Cancer Cells via NF-κB and PIN1 Pathways
Evid. Based Complement Altern. Med Yu 2019 2019 10.1155/2019/5213028 Cudraxanthone D Regulates Epithelial-Mesenchymal Transition by Autophagy Inhibition in Oral Squamous Cell Carcinoma Cell Lines
BioMed. Res. Int. Shin 2014 1 2014 10.1155/2014/934691 Isocudraxanthone K Induces Growth Inhibition and Apoptosis in Oral Cancer Cells via Hypoxia Inducible Factor-1 α
Exp. Ther. Med. Zhang 9 105 2015 10.3892/etm.2014.2077 Inhibitory effects and mechanism of 5-fluorouracil combined with celecoxib on human gastric cancer xenografts in nude mice
Med Sci. Monit. Geng 24 556 2018 10.12659/MSM.908568 Usnic Acid Induces Cycle Arrest, Apoptosis, and Autophagy in Gastric Cancer Cells In Vitro and In Vivo
Arch. Toxicol. Kim 89 867 2015 10.1007/s00204-015-1472-2 Compromised MAPK signaling in human diseases: an update
Biochim Biophys. Acta Kim 1802 396 2010 10.1016/j.bbadis.2009.12.009 Pathological roles of MAPK signaling pathways in human diseases
Int J. Oncol. Fu 2019 10.3892/ijo.2019.4744 Solamargine inhibits gastric cancer progression by regulating the expression of lncNEAT1_2 via the MAPK signaling pathway
World J. Gastroenterol. Yang 21 11673 2015 10.3748/wjg.v21.i41.11673 Mitogen-activated protein kinase signaling pathway and invasion and metastasis of gastric cancer
World J. Gastroenterol. Fan 25 2898 2019 10.3748/wjg.v25.i23.2898 NIMA related kinase 2 promotes gastric cancer cell proliferation via ERK/MAPK signaling
Mol. Syst. Biol. Neumann 6 352 2010 10.1038/msb.2010.6 Dynamics within the CD95 death-inducing signaling complex decide life and death of cells
PLoS One Yang 10 2015 Fas Signaling Promotes Gastric Cancer Metastasis through STAT3-Dependent Upregulation of Fascin
Recent Results Cancer Res Zeiser 211 91 2018 10.1007/978-3-319-91442-8_7 Trametinib (GSK1120212)
Magy. Onkol. Liszkay 57 110 2013 [Vemurafenib (Zelboraf) in the therapy of melanoma]
Hell. J. Cardiol. Raftopoulos 60 256 2019 10.1016/j.hjc.2018.09.003 Cardiotoxicity after vemurafenib administration
Lancet Oncol. Larkin 15 436 2014 10.1016/S1470-2045(14)70051-8 Vemurafenib in patients with BRAF(V600) mutated metastatic melanoma: an open-label, multicentre, safety study
BMC Ophthalmol. Sarny 17 146 2017 10.1186/s12886-017-0541-0 Ocular toxicity due to Trametinib and Dabrafenib
Tumour Biol. Lim 37 6205 2016 10.1007/s13277-015-4485-9 The alkyllysophospholipid edelfosine enhances TRAIL-mediated apoptosis in gastric cancer cells through death receptor 5 and the mitochondrial pathway
Biol. Res Lee 43 225 2010 10.4067/S0716-97602010000200010 Ethyl acetate fraction from Cudrania tricuspidata inhibits IL-1β-induced rheumatoid synovial fibroblast proliferation and MMPs, COX-2 and PGE2 production
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.